Abstract
Current experience with ropeginterferon Alfa-2b in Ph negative myeloproliferative neoplasm at the Department of Internal Medicine – Haematology and Oncology in Brno
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have